Catalyst Wire Dossier Catalyst Wire Dossier

NNC172-2021

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC172-2021, covering 2017-02-27 to 2017-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects [Phase 1]

See pricing